Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836067 · ClinicalTrials.gov registry record · NA
Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT02836067 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 53 participants.
The verdict
NCT02836067, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how smoking affects the immune systems in people with HIV infection. The investigators would like to know if HIV infected smokers who quit smoking have different responses in their tissues from people who keep smoking.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Bronchoscopy
- PROCEDURE Blood Draw
- BEHAVIORAL Counseling
- OTHER Smoking Cessation drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836067
The ClinicalTrials.gov registry entry for NCT02836067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaires is the first listed.
NCT02836067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02836067 about?
NCT02836067 is a clinical study titled "Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation". The purpose of this study is to learn how smoking affects the immune systems in people with HIV infection. The investigators would like to know if HIV infected smokers who quit smoking have different responses in their tissues from people who keep smoking.
What is the current status of trial NCT02836067?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2017-06-15. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT02836067?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Bronchoscopy (PROCEDURE), Blood Draw (PROCEDURE), Counseling (BEHAVIORAL), Smoking Cessation drugs (OTHER).
Who is sponsoring clinical trial NCT02836067?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.